Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Device reuse: Several trade groups sign on Sept. 6 to manifesto calling for EU action to regulate all reprocessing of medical devices intended for single use by hospitals, reprocessors and original manufacturers. In addition to original drafters Eucomed and the Patients Association, new adopters include the European Medical Association, International Alliance of Patients' Organisations, Standing Committee of European Doctors of the EU and Standing Committee of Hospitals of the European Union (1"The Gray Sheet" April 29, 2002, p. 14). France, Italy, Germany, Portugal, Spain, Sweden and the UK have already introduced specific legislative measures against reuse, but the practice remains widespread on the continent, Eucomed notes. The 2final draft of the manifesto includes scientific evidence against reuse and legal implications of regulation...

You may also be interested in...



Anti-Reuse Campaign Escalates In Preparation For Greek EU Presidency

Device reuse initiatives will be a focus of end-of-year lobbying efforts as European device stakeholders look to lay the groundwork for a more receptive government audience in 2003

Anti-Reuse Campaign Escalates In Preparation For Greek EU Presidency

Device reuse initiatives will be a focus of end-of-year lobbying efforts as European device stakeholders look to lay the groundwork for a more receptive government audience in 2003

Stakeholders Welcome European TSE Directive, Relax MDD Review Concerns

Manufacturers of devices incorporating tissues or derivatives from animals should prepare for a six-month implementation period following year-end publication of a European transmissible spongiform encephalopathy (TSE) directive

Related Content

UsernamePublicRestriction

Register

SC143420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel